Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

A team of scientists, including Dr David Nasralla and Professor Peter Friend from the Nuffield Department of Surgical Sciences, have had their research featured on the cover of the prestigious journal Nature.

They found that preserving livers at body temperature helps to improve transplant success and to increase the number of viable donor livers available for transplant, which could lead to shorter waiting lists for patients and lower mortality rates.

In the first randomized study of its kind, the Consortium for Organ Preservation in Europe (COPE) clinical trial team at NDS compared conventional cold storage in an ice box with a technique called normothermic machine perfusion in 220 liver transplant patients. The device used for normothermic machine preservation was developed by OrganOx Ltd, a MedTech business spun-out from the University of Oxford as a result of a collaboration between Professor Friend and Professor Constantin Coussios (Institute of Biomedical Engineering).

NatureDr David Nasralla, who is lead author of the study, said: 'Having our work published by a journal as prestigious as Nature is a wonderful achievement and also a testament to the huge amount of work that went into this study and the two decades of dedication from Professor Friend and Professor Coussios that preceded it. Being featured on the front cover of the journal is a great privilege and unexpected honour that I think any academic could only dream of.'

The research appears in the 3 May 2018 edition of Nature.

The research was also recently featured as a news article on the University of Oxford website and BBC Health News.

Similar stories

Mr Gurdeep S. Mannu awarded Cancer Research UK Clinician Scientist Fellowship

Many congratulations to Mr Gurdeep S. Mannu who has been awarded a five-year Cancer Research UK Clinician Scientist Fellowship.

EndoNET randomises first patient of 2023

A trial investigating how effective endocrine treatment is, prior to surgery in post-menopausal women with breast cancer, has randomised its first patient of the year.

New Cochrane review on antihistamines for motion sickness

A new systematic review from Cochrane ENT at the Nuffield Department of Surgical Sciences says antihistamines are likely to reduce the risk of developing motion sickness (travel sickness) in susceptible adults under naturally occurring conditions of movement, but they may be more likely to cause drowsiness than placebo.

Blog posts

Marathon challenge for Prostate Cancer UK

Runners of all abilities started 2023 by challenging themselves to run 26.2 miles across January to fundraise for Prostate Cancer UK as part of the charity’s Run the Month: Marathon Edition.

Staff Census: We need you!

All Medical Sciences staff are invited to log into HR self-service and ensure their contact, diversity background and disability details are up to date. Between 6% and 27% of staff in the Division are missing their diversity data which makes it difficult to complete statutory reporting, understand or track our population changes and to plan actions around staff diversity and equality – make sure your data is complete today!

Oxford MedSci goes silver: 10 Years of Athena SWAN

The Medical Sciences Division is celebrating 10 years since its first Athena Swan bronze application, and the first year in which all 16 of its departments have achieved a silver award. The silver award recognises commitment to gender equality, understanding culture and context, and more. Read about our department’s hard work and innovation.